Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)

Market Cap	2.51B +2.8%
Revenue (ttm)	233.67M -35.1%
Net Income	24.32M -64.1%
EPS	0.37 -64.0%
Shares Out	66.26M
PE Ratio	103.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	522,566
Open	38.15
Previous Close	37.95
Day's Range	36.92 - 38.15
52-Week Range	36.87 - 50.83
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHE:301520

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides pharmaceutical research and clinical research services in China. The company offers service platform for pharmaceutical research, raw materials, clinical research, medical device services, biological sample analysis, SMO service, and statistical analysis. It also provides precision nutrition cooperation and ecosystem platform; and drug platform. The company was incorporated in 2006 and is based in Hefei, China.

• Industry: Commercial Physical and Biological Research
• Founded: 2006
• Employees: 362
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301520

Financial Performance

In 2025, SHE:301520's revenue was 274.18 million, a decrease of -27.67% compared to the previous year's 379.09 million. Earnings were 36.43 million, a decrease of -57.40%.